Literature DB >> 15180397

Pharmacokinetics of amoxycillin and the rate of depletion of its residues in pigs.

M R Martínez-Larrañaga1, A Anadón, M A Martínez, M J Díaz, M T Frejo, V J Castellano, G Isea, C O De la Cruz.   

Abstract

Six pigs were used in a two-period crossover study to investigate the pharmacokinetics of amoxycillin after single intravenous and oral doses of 20 mg/kg bodyweight. Twelve pigs were used to study the residues of the drug in muscle, kidney, liver and fat after they had received daily oral doses of 20 mg/kg amoxycillin for five days. The mean (sd) elimination half life (t1/2beta) and mean residence time of amoxycillin in plasma were 3.38 (0.30) and 3.54 (0.43) hours, respectively, after intravenous administration and 4.13 (0.50) and 4.47 (0.30) hours, respectively, after oral administration. After oral administration, the maximum plasma concentration (Cmax) was 7.37 (0.42) microg/ml and it was reached after 0.97 (0.29) hours. Six days after the last oral dose, the mean concentration of amoxycillin in the pigs' kidneys was 21.38 ng/g and in the liver it was 12.32 ng/g, but no amoxycillin could be detected in fat or muscle; the concentrations of amoxycillin in edible tissues were less than the European Union maximal residue limit of 50 microg/kg.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15180397     DOI: 10.1136/vr.154.20.627

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  2 in total

1.  The effects of amoxicillin treatment of newborn piglets on the prevalence of hernias and abscesses, growth and ampicillin resistance of intestinal coliform bacteria in weaned pigs.

Authors:  Jinhyeon Yun; Satu Olkkola; Marja-Liisa Hänninen; Claudio Oliviero; Mari Heinonen
Journal:  PLoS One       Date:  2017-02-15       Impact factor: 3.240

2.  Pharmacokinetics and relative bioavailability of an oral amoxicillin-apramycin combination in pigs.

Authors:  Chongshan Dai; Tingting Zhao; Xing Yang; Xilong Xiao; Tony Velkov; Shusheng Tang
Journal:  PLoS One       Date:  2017-04-20       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.